|By Business Wire||
|January 13, 2014 09:07 AM EST||
Next IT, developer of Alme, the world's most trusted virtual assistant platform, today announced a new partnership with Symplmed Pharmaceuticals LLC, a unique pharmaceutical company poised to simplify the prescribing and administration of essential medications through its patent pending technology, DyrctAxess. The two companies plan to launch a virtual health assistant, powered by the advanced Alme for Healthcare platform to empower clinicians and patients to achieve better clinical outcomes.
The new virtual health assistant will build on Symplmed’s already innovative medication access technology by assisting customers in tracking of their treatment plan. Alme for healthcare will support the DyrctAxess data gathering and monitoring technology as well as provide a personalized vehicle for patients to have questions answered 24 hours a day. And, when the need arises, the technology will be able to connect customers directly to the physician or customer service rep.
Symplmed, founded in 2013, is revolutionizing the way essential medications are prescribed and administered, focusing on making the process as efficient and effective as possible for the patient. Patients receive regular shipments of medications directly from the manufacturer, simplifying the experience and lowering costs. Symplmed’s patent pending DyrctAxess technology also connects physicians and patients via the web and mobile access so they can monitor treatment progress together.
“Symplmed is built with a singular focus on improving patient outcomes while minimizing physician and office burden. Through our DyrctAxess technology, we are revolutionizing how pharmaceuticals are commercialized,” said Symplmed CEO Erik Emerson. “Our partnership with Next IT is another step forward as we can now provide patients access to help and answers in a private, personalized, and nonjudgmental manner, 24 hours a day.”
By integrating the Alme for Healthcare-powered virtual health assistant into the DyrctAxess experience, patients and physicians will have the added benefit of Next IT’s industry leading A.I. software.
“Symplmed’s innovative approach to drug distribution and patient follow up is exactly the type of experience we wanted to foster when we launched Alme for Healthcare,” said Next IT CEO and founder Fred Brown. “Virtual health assistants have the power not only to increase patient engagement, but to revolutionize the entire treatment experience, bringing doctors and patients together as equal partners in an effective treatment plan.”
Symplmed and Next IT plan to launch the virtual health assistant to DyrctAxess users in Q3 2014.
Symplmed is a unique pharmaceutical company aiming to simplify the prescribing and administration of essential medications - with a focus on helping patients consistently achieve treatment goals.
Symplmed’s combination of patent-pending technology and well-established pharmaceutical products integrate point-of-care and post-office-visit follow-up, allowing greater attention on patient, physician and payer benefits.
For more information, please visit www.symplmed.com
About Next IT
Founded in 2002, Next IT has been at the forefront of virtual assistant technology for over a decade. Alme, Next IT’s flagship product, is the world’s most trusted virtual assistant platform. Customer experience leaders including Aetna, Alaska Airlines, Amtrak, United Airlines and the U.S. Army all rely on Alme to provide their customers with remarkable experiences every day.
In 2013 Next IT launched Alme for Healthcare, a revolutionary new platform that delivers advanced virtual assistant capabilities to healthcare-specific environments across mobile, web and chat interfaces.
Next IT is proudly based in Spokane, Washington. For more information, please visit: www.NextIT.com.